Profund Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Buy |
20,842
+8,131
| +64% | +$397K | 0.04% | 299 |
|
|
2025
Q1 | $648K | Sell |
12,711
-3,325
| -21% | -$169K | 0.03% | 405 |
|
|
2024
Q4 | $724K | Sell |
16,036
-4,710
| -23% | -$213K | 0.03% | 369 |
|
|
2024
Q3 | $770K | Buy |
20,746
+1,388
| +7% | +$51.5K | 0.03% | 390 |
|
|
2024
Q2 | $592K | Sell |
19,358
-26,787
| -58% | -$819K | 0.02% | 451 |
|
|
2024
Q1 | $1.34M | Sell |
46,145
-9,233
| -17% | -$269K | 0.05% | 275 |
|
|
2023
Q4 | $1.53M | Buy |
55,378
+20,002
| +57% | +$551K | 0.07% | 241 |
|
|
2023
Q3 | $793K | Sell |
35,376
-337
| -0.9% | -$7.55K | 0.04% | 339 |
|
|
2023
Q2 | $1.45M | Buy |
35,713
+6,392
| +22% | +$260K | 0.08% | 221 |
|
|
2023
Q1 | $1.42M | Buy |
+29,321
| New | +$1.42M | 0.09% | 195 |
|